Abstract: Oleanolic acid (3b-hydroxyolean-12-en-28-oic acid) is a pentacyclic triterpenoid compound with a wide spread occurrence throughout the plant kingdom. During the last decade many research articles associated with oleanolic acid have been published. Particularly its hepatoprotective activity has been studied for many years. However, the clinical application of oleanolic acid has been limited by its poor solubility. In order to overcome this disadvantage, various approaches have been sought and many derivatives of oleanolic acid have been designed and synthesized. And some of these analogues show improved pharmacokinetic and pharmacodynamic properties, indicating that it may be promising candidates for the treatment of human liver diseases.
INTRODUCTION
Oleanolic acid (OA, Figure 1 ) belongs to pentacyclic triterpenoid compound which exists widely in food or medicinal herbs [1] [2] . The chemistry of oleanane-type triterpenoids has been investigated with particular interest and many relevant biological and pharmacological activities of these derivatives have been reported in the literature, among which are antiinflammatory [3] [4] , antitumoral [5] , anticancer [6] , hypoglycaemic [7] , antiviral [8] [9] , antibacterial [10] [11] [12] [13] and antifungal [14] [15] [16] activities. OA is well known for its hepatoprotective effects on acute chemically induced liver injury, chronic liver fibrosis and cirrhosis. The hepatoprotective activity of OA was first reported in 1975 [17] . Then oleanolic acid soon became a registered drug for the clinical treatment of acute and chronic hepatitis in China [18] . The beneficial effects of OA on liver could be due to its anti-oxidant and antiinflammatory activities, and its effects on drug metabolizing enzymes [19] [20] [21] . However, the poor solubility of OA limits its extensive application. Therefore, development of new therapeutic reagents, particularly injectable drugs, will be of great significance [22] . In this paper, we will address more stable analogues of OA, and discuss their protective activity on liver. 
SYNTHESES AND HEPATOPROTECTIVE ACTIVITY
Organic synthesis provides a cheaper and more efficient approach to obtain large amounts of 'natural inspired' chemicals to therapeutics than by extracting few milligrams from the nature. The molecular diversity that arises from natural products research into organic synthesis represents a valuable tool for promoting drug discovery and development [23] . Water-solubility of OA was limited, which limits its widespread clinical application. Organic synthesis can provide a more efficient way to obtain large amounts of analogues for therapeutics. Therefore numerous researchers take more efforts to synthesize new derivatives of OA in order to strengthen its pharmacological actions.
In the early 2004, Li ZM et al. [24] studied the protective effects of OA and sodium on chemically liver injured rats. And the results showed that administration of OA and sodium can lower the serum ALT and AST activity more significantly than model group dose, hepatic pathological injury was abated in some degree.
Nitric oxide (NO) as a messenger plays an important role in vivo. The decreased availability of NO or dysfunction in NO signaling has often been implicated in the development and progression of diseases. Therefore, design and research synthesis of NO-donating drugs have become one of the important strategies in drug discovery. In 2007, Chen L et al. [25] synthesized some nitrate-OA hybrids (Table 1-3) as inhibitors of HepG2 cell apoptosis. Within these series of compounds, five of them showed improved inhibitory effects on anti-Fas-mediated hepatocyte apoptosis in vitro and the anti-apoptotic effects were dosedependent. And the compound 9 was the most potential inhibitor and protected hepatocytes from antiFa-smediated apoptosis at a lower dosage level. The quantitative structure-activity relationship (QSAR) analysis of these compounds revealed the connection of the A-ring of OA with an optimal length of linker and the C-28 of OA esters with anti-oxygen was crucial for their anti-apoptotic activities. Together, these findings may aid in the design of OA analogues for the intervention of human liver diseases in clinic. Then in 2008, Chen L. et al. [26] synthesized some nitric oxide releasing derivatives of OA (Table 4) with anti-hepatocellular carcinoma activity. By coupling Table 1 : Ma CM et al [27] synthesized some new nitric oxidereleasing glycosyl derivatives of OA ( Table 5) . To evaluate the related bioactivities of OA analogues on liver disease, 29 derivatives of several series were synthesized and tested for their inhibitory activity on hepatitis C viral protease. They also tested the cytotoxity and apoptosis-inducing effects of these analogues on HepG2 cells. The present results showed that the 3-amino-OA has possessed high cytotoxicity on HepG2 cells. The amino derivatives (53-55) showed potent cytotoxicity. Treatment with 54 increased the apoptosis and exhibited more distinct cytotoxicity than 53. The cytotoxicity of hemiesters and hemiamides varied depending on the chain lengths. For example, compounds 42-47 showed higher cytotoxicity than 40 and 41 which contained shorter chain lengths. Contrary to the cytotoxic activity, derivatives 53-55 with free amino showed little inhibitory activity on HCV protease. Compound 60 and all the hemisters 40-47 and hemiamides 56-59 showed high activity against HCV protease. The present results together with data aid in understanding the QSAR of OA derivatives on HepG2 cancer cells and the inhibition of HCV protease. The authors found that introduction of amino-group could enhance the cytotoxicity and that addition of acidic group increased the inhibition on HCV protease, which might guide the further design and synthesis of lead compounds as anti-human hepatocellular carcinoma and anti-HCV agents.
In 2010, Huang ZJ et al, [28] synthesized new nitric oxide-releasing glycosyl derivatives of OA ( Table 6) . A series of derivatives (67-69) of OA were designed and ), and its inhibitory effect was similar to that of 5-FU treatment. Importantly, the tumor weights in the mice treated with 67 at 12.5 or 25 mg·kg -1 was 0.48 ± 0.33g or 0.31 ± 0.13g, which were significantly lower than that from the vehicle-treated controls (0. 87±0.31 g, p <0.01) . Notably, the mean body weight in the mice treated with67was heavier than that of the mice treated with 5-FU at the end of this experiment.
Together, the data demonstrate that the NO releasing glycosyl derivative of OA is a potent inhibitor of the growth of solid HCC tumors and has a better safety in vivo. However, the precise mechanisms explaining the potent cytotoxicity of those compounds on HCC cells remained to be further investigated. Furthermore, the intracellular levels of NO produced by 68 in HCC cells were about 2-to 5-fold higher than that in non-HCC LO2 cells, which may be the key to its selective anti-HCC activity. The higher anti-HCC activity may be related to the easier entry of 68 into the cells, the NO releasing group with OA, and higher stability. As expected, compound 68 had a better aqueous solubility in order to be prepared for intravenous injection. Furthermore, compound 68 displayed low acute toxicity to mice and notably inhibited the growth of HCC tumors in vivo, which indicated that 68 could be prepared as injectable medicine for prevention of human HCC.
In 2011, Meng YQ et al [29] synthesized some OA derivatives (Table 7-8) and tested their anti-hepatoma activity. A few OA derivatives were designed and obtained by the reaction of oxidation, acylation or hydrolyzation, etc. The authors evaluated the cytotoxicity of OA derivatives against HepG2 in vitro through MTT assays. The results showed that compound 96 was obviously active to inhibit the growth of HepG2 cells, which was stronger than oleanolic acid. The QSAR analysis revealed that: Esterification with saccharide on 28-carboxy or the amidation with amine had significantly enhanced its anti-tumor activity in HepG2 cells, for example 72 > 75 > OA; The esterification on 28-position carboxyl group of the OA and extension of the nitrogen-containing carbon chain enhanced the anti-tumor activity on HepG2 cells, for example 78>77; The more hydroxyl groups the saccharide derivatives had, the stronger anti-hepatoma activity they exhibited, for example 76>75. The findings that addition of saccharide or amino-group enhanced the cytotoxicity may be value for designing and synthesizing of OA derivatives as lead compounds for liver diseases. ) and potent inhibition of HCC tumor growth in mice. Furthermore, 87 induced HCC cell apoptosis, which was accompanied by lower mitochondrial membrane potentials and Bcl2 expression, but with higher cytochrome C release, Bax, caspase 3 and 9 expression activities in HCC cells. It is expected that the biological studies described in this investigation will facilitate the design of new therapeutic agents for the clinical intervention of HCC disease.
CONCLUSION
A major advancement during the past 10 years was the synthesis of derivatives from the natural triterpenoids such as OA. Water solubility of OA is poor, thus leading to poor bioavailability in the body. Increasing the solubility of a compound often improves its bioavailability. Efforts have been made to improve its water solubility through structure modification. For example, hundreds of OA derivatives have been generated, some of which possess improved activities than OA [31] . Other synthetic derivatives, such as sodium salt analogues, also demonstrate more potent hepatoprotective effects with less toxicity. Chemical modification of raw natural compounds could produce more effective derivatives with less toxicity. Other means used to increase the solubility of OA include non-covalent complex with hydrophilic cyclodextrins, as well as the use of nanosuspensions [32] . In the present study, oleanolic acid nanosuspensions were prepared by the nanoprecipitation method and then systematically characterized [33] . Both pharmacokinetic and pharmacodynamic considerations are equally important in increasing the hepatoprotective effects of OA [34] . To achieve a more potent hepatoprotective activity, various derivatives could be synthesized by adding new groups to OA [35] . Which may represent a new frontier in the treatment of liver diseases. 
